Medical technology Clinical application Access assessment Informatization Supervise
南京中医药大学中医品牌专业建设教学改革课题（NZYZYXPPJG2017—22）
2018年11月，国家卫生健康委发布《医疗技术临床应用管理办法》，明确对禁止类等医疗技术临床应用实行负面清单及重点管理。此举赋予医疗机构在医疗技术管理暨临床应用方面更多的自由，调动了医疗技术发展活力。基于这一背景，作者在分析医疗技术管理发展趋势的前提下，探讨了目前医疗技术规范管理与临床应用的要点，并从医疗技术准入评估新模式和强化医疗技术临床应用事中事后信息化监管两个角度，探讨如何进一步完善医疗技术规范化管理暨应用，在新形势下强化医疗机构的主体责任，保障医疗质量与安全，维护患者健康权益。
On November 1st，2018，the National Health Commission officially issued the“Administrative Measures for the Clinical Application of Medical Technology”，which clearly implemented negative lists and key management of the clinical applications of pro⁃hibited medical technologies. This move has given medical institutions more freedom in the management and clinical application of medical technology，which has greatly stimulated the vitality of medical technology development. Based on this background，on the premise of analyzing the development trend of medical technology management，this article explored the main points of current medical technology standard management and clinical application，and studied how to further improve the standardized management and appli⁃cation of medical technology from the two aspects of exploring new models of medical technology access assessment and strengthening post-event supervision with the information-based means in clinical application of medical technology，which is of great significance to strengthening the main responsibility of medical institutions under the new situation，ensuring the quality and safety of medical care，and safeguarding the health rights of patients.